Sudarshan Pharma Industries Stock Forecast for 2023 - 2025 - 2030

Sudarshan Pharma Industries Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Sudarshan Pharma Industries's Revenue has grown by 211.73%, rising from Rp1.48B to Rp4.61B. For the following year, the 0 analysts predict that Sudarshan Pharma Industries's Revenue will drop by 46.54%, reaching Rp2.47B. In 2030, the professionals' prediction is that 543828's Revenue will decrease by 37.49%, reaching Rp2.88B.

Sudarshan Pharma Industries Dividend per Share Forecast for 2023 - 2025 - 2030

Sudarshan Pharma Industries Free Cash Flow Forecast for 2023 - 2025 - 2030

Sudarshan Pharma Industries EBITDA Forecast for 2023 - 2025 - 2030

Sudarshan Pharma Industries's EBITDA has seen impressive growth In the last two years, rising from Rp52.69M to Rp151.17M – a growth of 186.90%. According to the 0 analysts polled, in the next year, Sudarshan Pharma Industries's EBITDA will fall by 43.86%, reaching Rp84.87M. By 2030, professionals believe that Sudarshan Pharma Industries's EBITDA will have decreased by 36.20%, falling to Rp96.45M.

Sudarshan Pharma Industries EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Sudarshan Pharma Industries's EBIT has grown by 190.78%, rising from Rp49.22M to Rp143.12M. For the next year, 0 analysts project Sudarshan Pharma Industries's EBIT to drop by 44.42%, reaching Rp79.54M. By 2030, professionals believe that Sudarshan Pharma Industries's EBIT will decrease by 36.48%, reaching Rp90.91M – a concerning trend for the company.

Sudarshan Pharma Industries EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last year, Sudarshan Pharma Industries's EPS has grown by 100.00%, rising from Rp0.00 to Rp0.00. For next year, analysts predict EPS of Rp0.00, which would mean an increase of 100.00%. Over the next five years, experts predict that Sudarshan Pharma Industries's EPS will grow at a rate of 100.00%.